$BAC $FUJIF Analyst hasn’t done the patent search necessary to advise on #Avigan future revenue- 2016 deal with Chinese Big Pharma guarantees royalties as do worldwide (including US) patents valid through 2030. Buying Opportunity. https://t.co/IgDaQ8dZPe